Development of a novel-ionizable-lipid-based mRNA vaccine for broad protection against Streptococcus pneumoniae
{{output}}
Recently, messenger RNA (mRNA)-based vaccine technology has made significant advances in preventing pathogenic microbial infections. The composition and physicochemical properties of lipid nanoparticle (LNP) determine the delivery efficiency of mRNA vaccines. ... ...
